Enveric Biosciences, Inc. ENVB 深 沪
等待开盘 05-14 09:30:00 美东时间
2.44
-0.080
-3.17%
华盛通- 最 高2.64
- 今 开2.52
- 成交量 26.77万股
- 最 低 2.43
- 昨 收 2.52
- 总市值 484.47万
- 52周最高 17.64
- 市盈率 静 --
- 换手率 13.48%
- 52周最低 1.71
- 委 比 -27.55%
- 总股本 198.55万
- 历史最高 2700000.00
- 量 比 0.88
- 振 幅 8.33%
- 历史最低 1.71
- 每 手 1
- 风险率 5.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Enveric Biosciences Highlights Results for EB-003 In PTSD Preclinical Model; Says Previously Reported Results Support Continued Development Of EB-003 For PTSD, Other Neuropsychiatric Condition
Enveric Biosciences today highlighted preclinical data for its lead candidate, EB-003, a dual 5-HT2A and 5-HT1B modulator, in which a single dose of EB-003 significantly reduced context-induced freezing behavior one hour
05-05 20:00
Enveric Biosciences Corrects Reverse Stock Split Proxy Disclosure
The latest announcement is out from Enveric Biosciences ( ($ENVB) ). On April 1...
05-01 05:31
What's Going On With Enveric Biosciences Stock On Friday?
The FDA issues priority vouchers and clears early trials for ibogaine derivatives for using psychedelics for therapy and mental health.
04-25 02:13
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 63.0% to $0...
04-25 01:05
Enveric Biosciences Canada Granted U.S. Patent Over Carboxylated Psilocybin Derivatives And Methods Of Using
https://ppubs.uspto.gov/api/pdf/downloadPdf/12605361?requestToken=eyJzdWIiOiJiMmQyZjdhNi0yZmM0LTQ4YTItYWIxMS0wNzZhOTczYTU1MmEiLCJ2ZXIiOiI2ZTk5MmY4YS1kNmRjLTRlZGYtYTdkNy02NWZjZTkxM2E4MmMiLCJleHAiOjB9
04-22 02:46
BUZZ-Psychedelic drug developers rise after Trump signals regulatory support
BUZZ-Psychedelic drug developers rise after Trump signals regulatory support ** Shares of psychedelic drug developers rise premarket after U.S. President Donald Trump signed an executive order on Saturday, telling health regulators to speed up review of psychedelic drugs such as ibogaine and set asi
04-20 17:16
Enveric Biosciences prices $5 million at-the-market private placement at $2.25/share
Enveric Biosciences prices $5 million at-the-market private placement at $2.25/share Enveric Biosciences priced a private placement at-the-market under Nasdaq rules for 2,222,223 common shares or pre-funded warrants at USD 2.25 each. Gross proceeds expected at about USD 5 million. Offering includes
04-17 08:11
Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share
Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share Enveric Biosciences entered definitive agreements for an at-the-market private placement of 2,222,223 common shares, or pre-funded warrants, priced at USD 2.25 per share. Gross proceeds expected at about USD
04-17 08:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Psyence Biomedical (NASDAQ:PBM) shares increased by 63.4% to $9.59 dur...
04-17 05:05
'Trump To Sign Executive Order On Psychedelic Drug Used Abroad To Treat PTSD' - CBS News Exclusive
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
04-16 23:56
